Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA

Alcaraz, Mattheo; Roquet-Baneres, Francoise; Leon-Icaza, Stephen Adonai; Abendroth, Jan; Boudehen, Yves-Marie; Cougoule, Celine; Edwards, Thomas E.; Kremer, Laurent

doi:10.1021/acsinfecdis.2c00314

Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA

Journal Article · 01 September 2022 · ACS Infect. Dis.

DOI:https://doi.org/10.1021/acsinfecdis.2c00314· OSTI ID:1901315

Alcaraz, Mattheo; Roquet-Baneres, Francoise; Leon-Icaza, Stephen Adonai; Abendroth, Jan; Boudehen, Yves-Marie; Cougoule, Celine; Edwards, Thomas E.; Kremer, Laurent

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; FOREIGN

OSTI ID:: 1901315

Journal Information:: ACS Infect. Dis., Journal Name: ACS Infect. Dis. Journal Issue: (10) Vol. 8

Country of Publication:: United States

Language:: ENGLISH

References (65)

The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis Zhang, Ying; Heym, Beate; Allen, Bryan Nature, Vol. 358, Issue 6387 https://doi.org/10.1038/358591a0	journal	August 1992
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Daley, Charles L.; Iaccarino, Jonathan M.; Lange, Christoph European Respiratory Journal, Vol. 56, Issue 1 https://doi.org/10.1183/13993003.00535-2020	journal	July 2020
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A. American Journal of Respiratory and Critical Care Medicine, Vol. 175, Issue 4 https://doi.org/10.1164/rccm.200604-571ST	journal	February 2007
Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA McNeil, Matthew B.; Dennison, Devon; Shelton, Catherine Tuberculosis, Vol. 107 https://doi.org/10.1016/j.tube.2017.09.003	journal	December 2017
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery Prasad, Mayuri S.; Bhole, Ritesh P.; Khedekar, Pramod B. Bioorganic Chemistry, Vol. 115 https://doi.org/10.1016/j.bioorg.2021.105242	journal	October 2021
Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare Lopeman, Rose; Harrison, James; Desai, Maya Microorganisms, Vol. 7, Issue 3 https://doi.org/10.3390/microorganisms7030090	journal	March 2019
A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus Dupont, Christian; Viljoen, Albertus; Dubar, Faustine Molecular Microbiology, Vol. 101, Issue 3 https://doi.org/10.1111/mmi.13406	journal	June 2016
New use of BCG for recombinant vaccines Stover, C. K.; de la Cruz, V. F.; Fuerst, T. R. Nature, Vol. 351, Issue 6326 https://doi.org/10.1038/351456a0	journal	June 1991
Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent Halloum, Iman; Carrère-Kremer, Séverine; Blaise, Mickael Proceedings of the National Academy of Sciences, Vol. 113, Issue 29 https://doi.org/10.1073/pnas.1605477113	journal	July 2016
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease Bryan, Cassie M.; Bhandari, Janhavi; Napuli, Alberto J. Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 67, Issue 9 https://doi.org/10.1107/S1744309111018367	journal	August 2011
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria van Ingen, Jakko; Boeree, Martin J.; van Soolingen, Dick Drug Resistance Updates, Vol. 15, Issue 3 https://doi.org/10.1016/j.drup.2012.04.001	journal	June 2012
Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384 Halloum, Iman; Viljoen, Albertus; Khanna, Varun Antimicrobial Agents and Chemotherapy, Vol. 61, Issue 4 https://doi.org/10.1128/AAC.02509-16	journal	April 2017
Molecular Epidemiology of Mycobacterium abscessus , with Focus on Cystic Fibrosis Jönsson, Bodil E.; Gilljam, Marita; Lindblad, Anders Journal of Clinical Microbiology, Vol. 45, Issue 5 https://doi.org/10.1128/JCM.02592-06	journal	May 2007
Glycopeptidolipids, a Double-Edged Sword of the Mycobacterium abscessus Complex Gutiérrez, Ana Victoria; Viljoen, Albertus; Ghigo, Eric Frontiers in Microbiology, Vol. 9 https://doi.org/10.3389/fmicb.2018.01145	journal	June 2018
In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex Singh, S.; Bouzinbi, N.; Chaturvedi, V. Clinical Microbiology and Infection, Vol. 20, Issue 12 https://doi.org/10.1111/1469-0691.12780	journal	December 2014
KatG as Counterselection Marker for Nontuberculous Mycobacteria Gagliardi, Aron; Selchow, Petra; Luthra, Sakshi Antimicrobial Agents and Chemotherapy, Vol. 64, Issue 5 https://doi.org/10.1128/AAC.02508-19	journal	April 2020
The distinct fate of smooth and roughMycobacterium abscessusvariants inside macrophages Roux, Anne-Laure; Viljoen, Albertus; Bah, Aïcha Open Biology, Vol. 6, Issue 11 https://doi.org/10.1098/rsob.160185	journal	November 2016
Demonstration of Cord Formation by Rough Mycobacterium abscessus Variants: Implications for the Clinical Microbiology Laboratory Sánchez-Chardi, Alejandro; Olivares, Francesc; Byrd, Thomas F. Journal of Clinical Microbiology, Vol. 49, Issue 6 https://doi.org/10.1128/JCM.02322-10	journal	June 2011
Bactericidal and intracellular activity of β-lactams againstMycobacterium abscessus Lefebvre, Anne-Laure; Dubée, Vincent; Cortes, Mélanie Journal of Antimicrobial Chemotherapy, Vol. 71, Issue 6 https://doi.org/10.1093/jac/dkw022	journal	February 2016
TheMycobacterium tuberculosisFAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development Bhatt, Apoorva; Molle, Virginie; Besra, Gurdyal S. Molecular Microbiology, Vol. 64, Issue 6 https://doi.org/10.1111/j.1365-2958.2007.05761.x	journal	June 2007
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients Roux, Anne-Laure; Catherinot, Emilie; Soismier, Nathalie Journal of Cystic Fibrosis, Vol. 14, Issue 1 https://doi.org/10.1016/j.jcf.2014.07.004	journal	January 2015
Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response Nessar, Rachid; Reyrat, Jean-Marc; Davidson, Lisa B. Microbiology, Vol. 157, Issue 4 https://doi.org/10.1099/mic.0.046557-0	journal	April 2011
Covalent Modification of the Mycobacterium tuberculosis FAS-II Dehydratase by Isoxyl and Thiacetazone Grzegorzewicz, Anna E.; Eynard, Nathalie; Quémard, Annaïk ACS Infectious Diseases, Vol. 1, Issue 2 https://doi.org/10.1021/id500032q	journal	December 2014
Acute Respiratory Failure Involving an R Variant of Mycobacterium abscessus Catherinot, Emilie; Roux, Anne-Laure; Macheras, Edouard Journal of Clinical Microbiology, Vol. 47, Issue 1 https://doi.org/10.1128/JCM.01478-08	journal	January 2009
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance Luthra, Sakshi; Rominski, Anna; Sander, Peter Frontiers in Microbiology, Vol. 9 https://doi.org/10.3389/fmicb.2018.02179	journal	September 2018
Reinstating Mycobacterium massiliense and Mycobacterium bolletii as species of the Mycobacterium abscessus complex Adekambi, Toidi; Sassi, Mohamed; van Ingen, Jakko International Journal of Systematic and Evolutionary Microbiology, Vol. 67, Issue 8 https://doi.org/10.1099/ijsem.0.002011	journal	August 2017
Mycobacterium abscessus: a new antibiotic nightmare Nessar, R.; Cambau, E.; Reyrat, J. M. Journal of Antimicrobial Chemotherapy, Vol. 67, Issue 4 https://doi.org/10.1093/jac/dkr578	journal	January 2012
Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis Vilchèze, Catherine; Morbidoni, Hector R.; Weisbrod, Torin R. Journal of Bacteriology, Vol. 182, Issue 14 https://doi.org/10.1128/JB.182.14.4059-4067.2000	journal	July 2000
NTM drug discovery: status, gaps and the way forward Wu, Mu-Lu; Aziz, Dinah B.; Dartois, Véronique Drug Discovery Today, Vol. 23, Issue 8 https://doi.org/10.1016/j.drudis.2018.04.001	journal	August 2018
Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessus Madani, Abdeldjalil; Ridenour, Jeremy N.; Martin, Benjamin P. ACS Infectious Diseases, Vol. 5, Issue 9 https://doi.org/10.1021/acsinfecdis.9b00172	journal	July 2019
Heterologous Expression of ethA and katG in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosis Ho, Vien Q. T.; Verboom, Theo; Rong, Mark K. Antimicrobial Agents and Chemotherapy, Vol. 65, Issue 4 https://doi.org/10.1128/AAC.01445-20	journal	March 2021
Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus Johansen, Matt D.; Daher, Wassim; Roquet-Banères, Françoise Antimicrobial Agents and Chemotherapy, Vol. 64, Issue 11 https://doi.org/10.1128/AAC.00363-20	journal	October 2020
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase Kuo, Mack R.; Morbidoni, Hector R.; Alland, David Journal of Biological Chemistry, Vol. 278, Issue 23 https://doi.org/10.1074/jbc.M211968200	journal	June 2003
Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD ⁺ and a C16 Fatty Acyl Substrate Rozwarski, Denise A.; Vilchèze, Catherine; Sugantino, Michele Journal of Biological Chemistry, Vol. 274, Issue 22 https://doi.org/10.1074/jbc.274.22.15582	journal	May 1999
Mycobacteria–host interactions in human bronchiolar airway organoids Iakobachvili, Nino; Leon‐Icaza, Stephen Adonai; Knoops, Kèvin Molecular Microbiology, Vol. 117, Issue 3 https://doi.org/10.1111/mmi.14824	journal	November 2021
Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation Bernut, Audrey; Herrmann, Jean-Louis; Kissa, Karima Proceedings of the National Academy of Sciences, Vol. 111, Issue 10 https://doi.org/10.1073/pnas.1321390111	journal	February 2014
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections Wallace, R. J.; Dukart, G.; Brown-Elliott, B. A. Journal of Antimicrobial Chemotherapy, Vol. 69, Issue 7 https://doi.org/10.1093/jac/dku062	journal	March 2014
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid Vilchèze, Catherine; Wang, Feng; Arai, Masayoshi Nature Medicine, Vol. 12, Issue 9 https://doi.org/10.1038/nm1466	journal	August 2006
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung Kirchner, Sebastian; Fothergill, Joanne L.; Wright, Elli A. Journal of Visualized Experiments, Issue 64 https://doi.org/10.3791/3857	journal	June 2012
Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members: MmpL activity is dependent on a crucial tyrosine Bernut, Audrey; Viljoen, Albertus; Dupont, Christian Molecular Microbiology, Vol. 99, Issue 5 https://doi.org/10.1111/mmi.13283	journal	December 2015
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus Johansen, Matt D.; Herrmann, Jean-Louis; Kremer, Laurent Nature Reviews Microbiology, Vol. 18, Issue 7 https://doi.org/10.1038/s41579-020-0331-1	journal	February 2020
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex Lavollay, M.; Dubée, V.; Heym, B. Clinical Microbiology and Infection, Vol. 20, Issue 5 https://doi.org/10.1111/1469-0691.12405	journal	May 2014
Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus Raynaud, Clément; Daher, Wassim; Johansen, Matt D. ACS Infectious Diseases, Vol. 6, Issue 2 https://doi.org/10.1021/acsinfecdis.9b00389	journal	December 2019
Spontaneous Formation of the Bioactive Form of the Tuberculosis Drug Isoniazid Wilming, Martin; Johnsson, Kai Angewandte Chemie International Edition, Vol. 38, Issue 17 https://doi.org/10.1002/(SICI)1521-3773(19990903)38:17<2588::AID-ANIE2588>3.0.CO;2-8	journal	September 1999
Non-tuberculous mycobacterial pulmonary disease Cowman, Steven; van Ingen, Jakko; Griffith, David E. European Respiratory Journal, Vol. 54, Issue 1 https://doi.org/10.1183/13993003.00250-2019	journal	June 2019
Immobilized metal-affinity chromatography protein-recovery screening is predictive of crystallographic structure success Choi, Ryan; Kelley, Angela; Leibly, David Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 67, Issue 9 https://doi.org/10.1107/S1744309111017374	journal	August 2011
The Integrated Resource for Reproducibility in Macromolecular Crystallography: Experiences of the first four years Grabowski, Marek; Cymborowski, Marcin; Porebski, Przemyslaw J. Structural Dynamics, Vol. 6, Issue 6 https://doi.org/10.1063/1.5128672	journal	November 2019
Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections Kozikowski, Alan P.; Onajole, Oluseye K.; Stec, Jozef Journal of Medicinal Chemistry, Vol. 60, Issue 13 https://doi.org/10.1021/acs.jmedchem.7b00582	journal	June 2017
Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease Dick, Thomas Frontiers in Microbiology, Vol. 11 https://doi.org/10.3389/fmicb.2020.00371	journal	February 2020
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary Floto, R. Andres; Olivier, Kenneth N.; Saiman, Lisa Thorax, Vol. 71, Issue 1 https://doi.org/10.1136/thoraxjnl-2015-207983	journal	December 2015
EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets Dover, Lynn G.; Alahari, Anuradha; Gratraud, Paul Antimicrobial Agents and Chemotherapy, Vol. 51, Issue 3 https://doi.org/10.1128/AAC.01063-06	journal	March 2007
Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria Kremer, Laurent; Dover, Lynn G.; Morbidoni, Hector R. Journal of Biological Chemistry, Vol. 278, Issue 23 https://doi.org/10.1074/jbc.M302435200	journal	June 2003
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis Rozwarski, D. A. Science, Vol. 279, Issue 5347 https://doi.org/10.1126/science.279.5347.98	journal	January 1998
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis Banerjee, A.; Dubnau, E.; Quemard, A. Science, Vol. 263, Issue 5144 https://doi.org/10.1126/science.8284673	journal	January 1994
Mn(III) Pyrophosphate as an Efficient Tool for Studying the Mode of Action of Isoniazid on the InhA Protein of Mycobacterium tuberculosis Nguyen, Michel; Quémard, Annaïk; Broussy, Sylvain Antimicrobial Agents and Chemotherapy, Vol. 46, Issue 7 https://doi.org/10.1128/AAC.46.7.2137-2144.2002	journal	July 2002
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus Koh, Won-Jung; Jeon, Kyeongman; Lee, Nam Yong American Journal of Respiratory and Critical Care Medicine, Vol. 183, Issue 3 https://doi.org/10.1164/rccm.201003-0395OC	journal	February 2011
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis Esther, Charles R.; Esserman, Denise A.; Gilligan, Peter Journal of Cystic Fibrosis, Vol. 9, Issue 2 https://doi.org/10.1016/j.jcf.2009.12.001	journal	March 2010
Direct inhibitors of InhA are active against Mycobacterium tuberculosis Manjunatha, U. H.; S. Rao, S. P.; Kondreddi, R. R. Science Translational Medicine, Vol. 7, Issue 269 https://doi.org/10.1126/scitranslmed.3010597	journal	January 2015
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria Brown-Elliott, Barbara A.; Nash, Kevin A.; Wallace, Richard J. Clinical Microbiology Reviews, Vol. 25, Issue 3 https://doi.org/10.1128/CMR.05030-11	journal	July 2012
Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype Howard, Susan T.; Rhoades, Elizabeth; Recht, Judith Microbiology, Vol. 152, Issue 6 https://doi.org/10.1099/mic.0.28625-0	journal	June 2006
Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo Viljoen, Albertus; Richard, Matthias; Nguyen, Phuong Chi Journal of Biological Chemistry, Vol. 293, Issue 8 https://doi.org/10.1074/jbc.RA117.000760	journal	January 2018
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance Rawat, R.; Whitty, A.; Tonge, P. J. Proceedings of the National Academy of Sciences, Vol. 100, Issue 24 https://doi.org/10.1073/pnas.2235848100	journal	November 2003
Overexpression, Purification, and Characterization of the Catalase-peroxidase KatG from Mycobacterium tuberculosis Johnsson, Kai; Froland, Wayne A.; Schultz, Peter G. Journal of Biological Chemistry, Vol. 272, Issue 5 https://doi.org/10.1074/jbc.272.5.2834	journal	January 1997

Similar Records

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA

Journal Article · 2018 · Life Science Alliance · OSTI ID:1545852

High Affinity Inha Inhibitors with Activity Against Drug-Resistant Strains of Mycobacterium Tuberculosis

Journal Article · 2005 · ACS Chem. Biol. · OSTI ID:914315

Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase

Journal Article · 2015 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1239783

Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA

Citation Formats

References (65)

Similar Records

Related Subjects